{"id":34977,"date":"2025-06-10T17:28:51","date_gmt":"2025-06-10T09:28:51","guid":{"rendered":"https:\/\/flcube.com\/?p=34977"},"modified":"2025-06-10T17:28:53","modified_gmt":"2025-06-10T09:28:53","slug":"suzhou-sinus-medtech-wins-fda-breakthrough-designation-for-ohcm-ablation-system","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=34977","title":{"rendered":"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System"},"content":{"rendered":"\n

Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house developed interventricular radiofrequency ablation system has received the Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA). This recognition is for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), a condition characterized by thickened heart muscle that can impair blood flow and lead to serious cardiovascular complications.<\/p>\n\n\n\n

Company Overview<\/strong>
Sinus Medtech is dedicated to developing cutting-edge devices for the management of major cardiovascular diseases. Its robust product pipeline is particularly focused on solutions for heart failure and atrial fibrillation, addressing significant unmet clinical needs in the cardiovascular space.<\/p>\n\n\n\n

Device and Innovation<\/strong>
The interventricular radiofrequency ablation system is designed to provide a minimally invasive treatment option for patients with oHCM. By leveraging advanced radiofrequency technology, the system aims to precisely target and ablate overgrown heart muscle tissue, thereby improving blood flow and reducing symptoms associated with the condition.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house…<\/p>\n","protected":false},"author":1,"featured_media":34979,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[34,69,4134],"class_list":["post-34977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-breakthrough-therapy","tag-cvd","tag-sinus-medical-technologies"],"yoast_head":"\nSuzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house developed interventricular radiofrequency ablation system has received the Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA). This recognition is for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), a condition characterized by thickened heart muscle that can impair blood flow and lead to serious cardiovascular complications.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=34977\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System\" \/>\n<meta property=\"og:description\" content=\"Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house developed interventricular radiofrequency ablation system has received the Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA). This recognition is for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), a condition characterized by thickened heart muscle that can impair blood flow and lead to serious cardiovascular complications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=34977\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-10T09:28:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-10T09:28:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1010.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System\",\"datePublished\":\"2025-06-10T09:28:51+00:00\",\"dateModified\":\"2025-06-10T09:28:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977\"},\"wordCount\":169,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1010.webp\",\"keywords\":[\"Breakthrough therapy\",\"CVD\",\"Sinus Medical Technologies\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34977#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=34977\",\"name\":\"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1010.webp\",\"datePublished\":\"2025-06-10T09:28:51+00:00\",\"dateModified\":\"2025-06-10T09:28:53+00:00\",\"description\":\"Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house developed interventricular radiofrequency ablation system has received the Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA). This recognition is for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), a condition characterized by thickened heart muscle that can impair blood flow and lead to serious cardiovascular complications.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34977\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1010.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1010.webp\",\"width\":1080,\"height\":608,\"caption\":\"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34977#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System - Insight, China's Pharmaceutical Industry","description":"Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house developed interventricular radiofrequency ablation system has received the Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA). This recognition is for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), a condition characterized by thickened heart muscle that can impair blood flow and lead to serious cardiovascular complications.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=34977","og_locale":"en_US","og_type":"article","og_title":"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System","og_description":"Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house developed interventricular radiofrequency ablation system has received the Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA). This recognition is for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), a condition characterized by thickened heart muscle that can impair blood flow and lead to serious cardiovascular complications.","og_url":"https:\/\/flcube.com\/?p=34977","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-06-10T09:28:51+00:00","article_modified_time":"2025-06-10T09:28:53+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1010.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=34977#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=34977"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System","datePublished":"2025-06-10T09:28:51+00:00","dateModified":"2025-06-10T09:28:53+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=34977"},"wordCount":169,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=34977#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1010.webp","keywords":["Breakthrough therapy","CVD","Sinus Medical Technologies"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=34977#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=34977","url":"https:\/\/flcube.com\/?p=34977","name":"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=34977#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=34977#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1010.webp","datePublished":"2025-06-10T09:28:51+00:00","dateModified":"2025-06-10T09:28:53+00:00","description":"Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house developed interventricular radiofrequency ablation system has received the Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA). This recognition is for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), a condition characterized by thickened heart muscle that can impair blood flow and lead to serious cardiovascular complications.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=34977#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=34977"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=34977#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1010.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1010.webp","width":1080,"height":608,"caption":"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=34977#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1010.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34977"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34977\/revisions"}],"predecessor-version":[{"id":34980,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34977\/revisions\/34980"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/34979"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}